- Home
- AVD vs CMPX Comparison
AVD vs CMPX Comparison
Compare AVD & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- CMPX
- Stock Information
- Founded
- AVD 1969
- CMPX 2014
- Country
- AVD United States
- CMPX United States
- Employees
- AVD N/A
- CMPX N/A
- Industry
- AVD Agricultural Chemicals
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- AVD Industrials
- CMPX Health Care
- Exchange
- AVD Nasdaq
- CMPX Nasdaq
- Market Cap
- AVD 104.4M
- CMPX 291.8M
- IPO Year
- AVD N/A
- CMPX N/A
- Fundamental
- Price
- AVD $4.15
- CMPX $2.78
- Analyst Decision
- AVD Strong Buy
- CMPX Strong Buy
- Analyst Count
- AVD 1
- CMPX 9
- Target Price
- AVD $12.00
- CMPX $12.67
- AVG Volume (30 Days)
- AVD 259.0K
- CMPX 929.9K
- Earning Date
- AVD 08-07-2025
- CMPX 08-11-2025
- Dividend Yield
- AVD N/A
- CMPX N/A
- EPS Growth
- AVD N/A
- CMPX N/A
- EPS
- AVD N/A
- CMPX N/A
- Revenue
- AVD $527,962,999.00
- CMPX $850,000.00
- Revenue This Year
- AVD N/A
- CMPX N/A
- Revenue Next Year
- AVD $3.54
- CMPX N/A
- P/E Ratio
- AVD N/A
- CMPX N/A
- Revenue Growth
- AVD N/A
- CMPX N/A
- 52 Week Low
- AVD $3.28
- CMPX $0.77
- 52 Week High
- AVD $9.84
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- AVD 49.56
- CMPX 68.90
- Support Level
- AVD $3.54
- CMPX $2.50
- Resistance Level
- AVD $4.12
- CMPX $2.71
- Average True Range (ATR)
- AVD 0.25
- CMPX 0.19
- MACD
- AVD 0.01
- CMPX 0.01
- Stochastic Oscillator
- AVD 57.73
- CMPX 87.14
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.